<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David H Spach, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cat scratch disease (CSD) is an infectious disease that is typically characterized by self-limited regional lymphadenopathy. The manifestations of CSD, however, can include visceral organ, neurologic, and ocular involvement [<a href="#rid1">1,2</a>].</p><p>The microbiology, epidemiology, clinical features, and diagnosis of CSD will be reviewed here. The treatment of CSD, as well as the evaluation and management of cat bites, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5530.html" rel="external">"Treatment of cat scratch disease"</a> and  <a class="medical medical_review" href="/z/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Although clinical descriptions of CSD existed for more than 50 years, the first convincing evidence of an infectious cause of CSD came in 1983 when investigators at the Armed Forces Institute of Pathology, using a Warthin-Starry stain, demonstrated small, pleomorphic organisms in the lymph nodes of 29 of 34 patients with CSD [<a href="#rid3">3</a>]. Available serologic and culture data provide convincing evidence that <em>Bartonella henselae</em> is the etiologic agent in most cases of CSD [<a href="#rid4">4-6</a>]. In humans and cats, two main <em>B. henselae</em> genotypic groups have been identified based on molecular analysis: the Houston-1 serotype and Marseille serotype [<a href="#rid7">7</a>]. One report also described a case of CSD caused by <em>Bartonella clarridgeiae</em> [<a href="#rid8">8</a>]. In addition, scattered, uncommon cases of CSD may result from <em>Afipia felis</em>, <em>B. clarridgeiae</em>, and perhaps other, as yet unidentified, fastidious organisms [<a href="#rid9">9</a>].</p><p>Among persons with HIV (and less commonly other immunocompromised individuals), <em>B. henselae</em> can cause bacillary angiomatosis (BA), peliosis hepatis, and splenitis (see  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV"</a>). Rare reports have also documented BA among immunocompetent individuals [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of CSD remains poorly understood. Disease manifestations result from either local infection, such as lymphadenopathy, or from bloodborne disseminated infection, such as occurs with neuroretinitis or visceral organ involvement. Cats serve as the natural reservoir for <em>B. henselae</em>, and the organism causes intraerythrocytic bacteremia that can persist for a year or longer in some cats [<a href="#rid11">11</a>]. Following inoculation of <em>B. henselae</em> into humans, the organism typically causes a local infection that manifests as regional lymphadenopathy. Within the human host, <em>B. henselae</em> invades endothelial cells causing an acute inflammatory reaction associated with activation of a proinflammatory cascade [<a href="#rid12">12</a>]. It remains unknown why some persons with CSD have infection that remains localized whereas others develop disseminated disease. Some evidence suggests that the presence of the major histocompatibility human leukocyte antigen (HLA) B27 may predispose patients with <em>B. henselae</em> infection to develop uveitis [<a href="#rid13">13</a>]. </p><p class="headingAnchor" id="H4"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>CSD generally occurs in immunocompetent individuals and infrequently causes serious illness [<a href="#rid14">14</a>]. Although most commonly a disease of children and young adults, a surveillance study conducted in Israel found that 52 of 846 (6 percent) immunocompetent patients with CSD were ≥60 years of age [<a href="#rid15">15</a>]. Systemic CSD has been described in patients following solid organ transplantation and hematopoietic cell transplantation [<a href="#rid16">16-19</a>]. (See <a class="local">'Clinical manifestations'</a> below.)</p><p>Epidemiologic studies from the United States, Europe, Israel, Australia, and Japan, suggest that CSD has a worldwide distribution [<a href="#rid20">20</a>]. In a study from Germany, CSD was identified in 61 of 454 patients (13 percent) with primary head and neck masses [<a href="#rid21">21</a>]. In the United States, a retrospective study of patients younger than 65 years of age identified 13,273 patients with a diagnosis of CSD from 2005 to 2013 [<a href="#rid22">22</a>]. In this study, approximately 12,000 cases of CSD were diagnosed annually in the outpatient setting and 500 persons with CSD were hospitalized each year. The cases had a seasonal distribution with a peak in January and late summer and fall. In this analysis, the incidence of CSD was highest among those who lived in the southeastern United States (6.4 cases/100,000 population) and in children 5 to 9 years of age (9.4 cases/100,000 population). The incidence of atypical CSD (involving the eye, heart, liver, spleen, etc) in the United States was estimated to be 0.7 cases/100,000 and occurred most commonly in individuals 15 to 49 years of age [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H5"><span class="h1">TRANSMISSION</span><span class="headingEndMark"> — </span>Available data suggest that CSD can result from a scratch or bite from a cat infected with <em>B</em>. <em>henselae</em>, as well as from exposure to cat fleas infected with <em>B</em>. <em>henselae</em>. Transmission to humans can also occur via contact of cat saliva with broken skin or mucosal surfaces (eg, mouth and eyes). Although cats are the main reservoir for <em>B. henselae</em> [<a href="#rid24">24</a>], rare cases of CSD have occurred after exposure to dogs, presumably resulting from flea bites. Rarely, CSD occurs in family clusters with more than one child in the family presenting simultaneously with clinical disease [<a href="#rid25">25</a>]. </p><p>Multiple lines of evidence have directly linked CSD to exposure to cats, especially young cats and cats with fleas [<a href="#rid1">1,5,26</a>]. The cat flea, <em>Ctenocephalides felis</em>, plays a critical role in the horizontal cat-to-cat transmission of <em>B. henselae</em> [<a href="#rid27">27</a>]. In one study of 205 cats in northern California, <em>B. henselae</em> bacteremia was documented in 56 percent of cats less than one year of age and in 34 percent of cats over one year of age [<a href="#rid28">28</a>]. Moreover, 90 percent of cats younger than one year of age and 77 percent one year of age or older had a positive <em>B. henselae</em> serologic test. Most cats infected with <em>B. henselae</em> do not show clinical signs of infection [<a href="#rid29">29</a>].</p><p>Fleas have also been implicated in transmission of CSD. In one study of 60 persons with CSD (cases) and 56 age-matched controls, exposure to kittens (odds ratio [OR] 15), a scratch or bite by a kitten (OR 27), and having a kitten with fleas (OR 29) were more common among cases than controls [<a href="#rid5">5</a>]. In a study of <em>B. henselae</em> antibodies in catteries, flea infestation was the risk factor most associated with high seroprevalence [<a href="#rid30">30</a>]. Topical treatments that prevent flea infestations may have a role in preventing transmission of <em>B. henselae</em> from fleas to cats [<a href="#rid31">31-33</a>]. As an example, one study evaluated the use of topical selamectin (a commercially available parasiticide) to prevent transmission of <em>B. henselae </em>in 12 cats who were exposed to <em>B. henselae</em>-positive fleas [<a href="#rid31">31</a>]. Six of the cats were treated with topical 6% selamectin three days prior to and one day after being exposed to the fleas, and six cats received no treatment. None of the treated cats developed <em>B. henselae</em> infection; however, all of the untreated cats developed <em>B. henselae</em> bacteremia. </p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>CSD presents in 85 to 90 percent of children as a localized cutaneous and lymph node disorder near the site of organism inoculation. However, in some individuals, the organisms disseminate and infect the liver, spleen, eye, or central nervous system. Patients with localized disease generally have a self-limited illness, whereas those with disseminated disease can have life-threatening complications.</p><p>Older patients with CSD are more likely to present with atypical features. In the surveillance study in Israel mentioned above, clinical data for patients with CSD aged ≥60 years (older group) were compared with patients with CSD aged &lt;60 years (younger group) [<a href="#rid15">15</a>]. Lymphadenitis, the hallmark of typical CSD, was less common in the older group compared with those &lt;60 years of age (77 versus 94 percent). By contrast, the older group was more likely to have general malaise (71 versus 51 percent) and atypical manifestation (33 versus 14 percent), including endocarditis (odds ratio [OR] 61.6, 95% CI 12.4-305.1), encephalitis (OR 6.3, 95% CI 1.2-33.3), and fever of unknown origin (FUO; OR 7.3, 95% CI 2.2-24.5). For these reasons, the time from onset of symptoms to diagnosis of CSD in older persons was delayed by &gt;6 weeks when compared with the younger patients (30 versus 13 percent in the younger group). </p><p class="headingAnchor" id="H7"><span class="h2">Cutaneous manifestations</span><span class="headingEndMark"> — </span>CSD often begins with a cutaneous lesion at the site of inoculation, the so-called primary inoculation lesion. This lesion usually develops 3 to 10 days after the introduction of the organism into the skin and generally evolves through vesicular, erythematous, and papular phases [<a href="#rid34">34,35</a>]  (<a class="graphic graphic_picture graphicRef78770" href="/z/d/graphic/78770.html" rel="external">picture 1</a>). Less commonly, the primary inoculation lesion can be pustular or nodular. One report described a patient who developed a paronychia (painful periungual inflammation) caused by <em>B. henselae</em> as a manifestation of an inoculation site lesion [<a href="#rid36">36</a>]. The primary inoculation lesion typically persists for one to three weeks (range several days to several months).</p><p>Careful examination of the interdigital spaces, skin creases, and scalp increases the chance of finding the primary inoculation lesion. Inoculation sites other than the skin occur in about 5 to 10 percent of cases and include the eye (nonsuppurative conjunctivitis, ocular granuloma) and mucous membranes (oral ulcer) [<a href="#rid34">34</a>]. The inoculation lesions usually cause minimal symptoms and heal without scarring.</p><p>Other uncommon cutaneous manifestations of CSD include a transient macular and papular eruption, erythema multiforme, erythema nodosum, and thrombocytopenic purpura [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Lymphadenopathy</span><span class="headingEndMark"> — </span>Regional lymphadenopathy is the hallmark of CSD. Enlarged lymph nodes appear proximal to the inoculation site, about two weeks (range, 7 to 60 days) after the organism is inoculated into the skin  (<a class="graphic graphic_picture graphicRef52407" href="/z/d/graphic/52407.html" rel="external">picture 2</a>). The location of the lymphadenopathy typically correlates with the inoculation site. The most common locations are the axillary, epitrochlear, cervical, supraclavicular, and submandibular lymph nodes, although lymphadenopathy at other sites has also been reported [<a href="#rid37">37-39</a>].</p><p>The nodes are almost always tender, often have erythema of the overlying skin, and occasionally suppurate (10 to 15 percent). Node size typically ranges from 1 to 5 cm, but may enlarge to 8 to 10 cm. Lymphadenopathy associated with CSD usually resolves in one to four months, but reports have described persistence of enlarged nodes for one to three years. </p><p>In one study, solitary lymphadenopathy occurred in approximately 85 percent of persons with CSD [<a href="#rid35">35</a>]. Less commonly, patients presented with several enlarged nodes in the same anatomic region. In another study, regional adenopathy (single or multiple nodes) occurred in approximately two-thirds of cases, with the remaining one-third of patients having enlarged nodes in several anatomic sites [<a href="#rid34">34</a>]. Generalized lymphadenopathy is rare. </p><p class="headingAnchor" id="H9"><span class="h2">Visceral organ involvement</span><span class="headingEndMark"> — </span>Visceral organ involvement is an unusual, but important, manifestation of CSD, particularly in children [<a href="#rid40">40-42</a>]; visceral organ CSD can involve the liver, spleen, or both. Patients may have persistent FUO, abdominal pain, and/or weight loss [<a href="#rid43">43</a>]. About half of children with visceral organ involvement have hepatomegaly or splenomegaly evident on physical examination [<a href="#rid43">43</a>]; the liver may be tender to palpation. Many of the patients with visceral involvement have no accompanying peripheral adenopathy. In one review, 100 of 832 patients (12 percent) with CSD had splenomegaly, but these were not patients in whom granulomatous splenitis was documented [<a href="#rid44">44</a>].</p><p>An abdominal computed tomography (CT) scan will typically show scattered, multiple defects in the liver and/or spleen that if biopsied, shows necrotizing granulomas  (<a class="graphic graphic_diagnosticimage graphicRef56489" href="/z/d/graphic/56489.html" rel="external">image 1</a>). Biopsies are now rarely performed because the clinical and imaging findings are so characteristic for disseminated CSD. These are manifested as hypoechoic areas on ultrasound.</p><p>The erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) is typically elevated and liver function tests may be mildly abnormal.</p><p class="headingAnchor" id="H10"><span class="h2">Fever of unknown origin</span><span class="headingEndMark"> — </span><em>B. henselae</em> infection should be considered in the initial evaluation of fever of unknown origin (FUO) and prolonged fever, particularly in children [<a href="#rid37">37,45,46</a>]. A prospective analysis of 146 children with FUO and prolonged fever found that <em>B. henselae</em> was the third most common infectious disease diagnosis [<a href="#rid47">47</a>]. Although some of these children presented with signs and symptoms consistent with typical CSD or hepatosplenic involvement, three of seven patients with confirmed <em>B. henselae</em> infection presented with FUO and no clinical or radiographic manifestations of typical or hepatosplenic CSD. However, <em>B. henselae</em> infection has been described as a cause of FUO in adults. In a series of 66 patients with prolonged fever due to <em>B. henselae</em> from Israel, almost 80 percent were adults [<a href="#rid48">48</a>]; about half the patients presented with a prolonged continuous fever, while a prolonged relapsing fever pattern occurred in the other half of the patients. (See  <a class="medical medical_review" href="/z/d/html/5996.html" rel="external">"Fever of unknown origin in children: Etiology", section on 'Cat scratch disease'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Ocular manifestations</span><span class="headingEndMark"> — </span>Ocular manifestations of CSD include Parinaud oculoglandular syndrome, neuroretinitis, papillitis, optic neuritis, and focal retinochoroiditis [<a href="#rid49">49-52</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Parinaud oculoglandular syndrome</span><span class="headingEndMark"> — </span>Parinaud oculoglandular syndrome is an atypical form of CSD, which is reported in 2 to 8 percent of patients with CSD. Parinaud oculoglandular syndrome is characterized by tender regional lymphadenopathy of the preauricular, submandibular, or cervical lymph nodes associated with infection of the conjunctiva, eyelid, or adjacent skin surface. Usual complaints include unilateral red eye, a foreign body sensation in the eye, and excessive watering of the eyes. Discharge may be serous or purulent and copious in some patients [<a href="#rid53">53,54</a>]. The inoculation of the organism occurs via a cat bite or lick near (or in) the eye, as well as by self-inoculation from another infected site. Serious ocular, orbital, or retinal complications almost never develop as a result of local extension of Parinaud oculoglandular syndrome.</p><p class="headingAnchor" id="H13"><span class="h3">Neuroretinitis</span><span class="headingEndMark"> — </span>Among all patients with CSD, neuroretinitis develops in about 1 to 2 percent. Neuroretinitis is a syndrome of acute visual loss from optic nerve edema associated with macular exudates; <em>B. henselae</em> is believed to be one of the most common infectious causes of neuroretinitis [<a href="#rid55">55</a>]. The high frequency of CSD as a cause of neuroretinitis is illustrated by a serologic study of patients with neuroretinitis that found 9 of 14 (64 percent) had either elevated IgM or IgG <em>B. henselae</em> titers [<a href="#rid56">56</a>].</p><p>Patients with neuroretinitis typically present with fever, malaise, and unilateral blurred vision [<a href="#rid57">57</a>]. On examination: </p><p class="bulletIndent1"><span class="glyph">●</span>Patients usually have unilateral involvement, with decreased visual acuity, often associated with an afferent pupillary defect. (See  <a class="medical medical_review" href="/z/d/html/5095.html" rel="external">"The detailed neurologic examination in adults"</a> and  <a class="medical medical_review" href="/z/d/html/15360.html" rel="external">"Detailed neurologic assessment of infants and children", section on 'Cranial nerves'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Retinal findings may include hemorrhages, cotton wool spots, and multiple discrete lesions in the deep retina [<a href="#rid57">57</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some patients develop a stellate macular exudate (known as a "macular star")  (<a class="graphic graphic_picture graphicRef69294" href="/z/d/graphic/69294.html" rel="external">picture 3</a>). Macular stars are due to vascular leakage from the optic nerve head, and can be seen on <a class="drug drug_general" data-topicid="8461" href="/z/d/drug information/8461.html" rel="external">fluorescein</a> angiography or optical coherence tomography angiography. Patients with <em>B. henselae</em>-induced neuroretinitis may not develop a macular star until one to four weeks after initial presentation, and the exudate may persist for months, despite resolution of the neuroretinitis [<a href="#rid49">49</a>].</p><p></p><p>Most patients with neuroretinitis appear to have a good long-term prognosis [<a href="#rid49">49,57</a>], although patients with macular exudates may have residual defects that include optic disk pallor, diminished contrast sensitivity, and altered color vision [<a href="#rid49">49</a>]. Other complications with neuroretinitis have been reported, including macular hole with posterior vitreous detachment [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Neurologic manifestations</span><span class="headingEndMark"> — </span>A wide range of neurologic manifestations has been described in patients with CSD, including [<a href="#rid58">58-60</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Encephalopathy (most common)</p><p class="bulletIndent1"><span class="glyph">●</span>Transverse myelitis</p><p class="bulletIndent1"><span class="glyph">●</span>Radiculitis</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebellar ataxia</p><p></p><p>Patients with encephalopathy typically develop abrupt confusion and disorientation, which may progress to coma, approximately one to six weeks after initially presenting with adenopathy. Most of these patients will develop seizures and some develop focal neurologic findings such as hemiparesis as a result of cerebral vasculitis [<a href="#rid59">59</a>].</p><p>Among patients with CSD encephalopathy, findings include [<a href="#rid58">58</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A normal CT scan of the brain – Most patients</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mild mononuclear pleocytosis in the cerebrospinal fluid (CSF; usually &lt;50 cells/microL) – 20 to 30 percent of patients</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An abnormal electroencephalogram – Most patients</p><p></p><p>Although patients typically recover from CSD encephalopathy within several weeks, some will have residual neurologic defects.</p><p class="headingAnchor" id="H15"><span class="h2">Musculoskeletal manifestations</span><span class="headingEndMark"> — </span>Severe and often disabling musculoskeletal manifestations may occur in patients with CSD [<a href="#rid61">61-65</a>]. In a surveillance study of 913 patients with CSD in Israel, 96 (10.5 percent) had musculoskeletal manifestations [<a href="#rid61">61</a>]. These included myalgia (6 percent), arthritis or arthralgia (5.5 percent), and less commonly tendinitis, osteomyelitis, and neuralgia.</p><p>The knee, ankle, wrist, hand, and elbow joints were the most frequently affected. Although joint symptoms usually resolve, five patients developed chronic arthropathy [<a href="#rid61">61,62</a>]. Multivariate analysis identified the following characteristics significantly associated with arthropathy (arthritis or arthralgia):</p><p class="bulletIndent1"><span class="glyph">●</span>Female sex (relative risk [RR], 1.89; 95% CI 1.01-3.52)</p><p class="bulletIndent1"><span class="glyph">●</span>Age greater than 20 years (RR, 11.0; 95% CI 4.3-28.2)</p><p class="bulletIndent1"><span class="glyph">●</span>Erythema nodosum (RR, 4.07; 95% CI 1.38-12.02)</p><p></p><p>A review of bone infection associated with CSD, published prior to the above study, found 47 cases reported in the literature [<a href="#rid63">63</a>]. The median age was nine years. Bone pain and fever were the predominant clinical manifestations and the most commonly affected sites were the vertebral column and pelvic girdle.</p><p class="headingAnchor" id="H16"><span class="h2">Other atypical manifestations</span><span class="headingEndMark"> — </span>Scattered reports have documented rare manifestations of CSD, including deep neck space infection [<a href="#rid66">66</a>], scalp eschar with neck lymphadenopathy [<a href="#rid67">67</a>], pneumonia, pleural effusion, pulmonary nodules [<a href="#rid68">68</a>], septic shock, thrombocytopenic purpura (TTP), and hypercalcemia. The hypercalcemia is associated with overproduction of calcitriol, the most active form of vitamin D, and appears to be related to granuloma formation [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/z/d/html/841.html" rel="external">"Hypercalcemia in granulomatous diseases"</a>.)</p><p>Individuals with solid-organ transplants may have atypical manifestations including TTP, hemophagocytosis, and visceral disease that can resemble post-transplant lymphoproliferative disorder [<a href="#rid19">19,70</a>]. (See  <a class="medical medical_review" href="/z/d/html/7335.html" rel="external">"Treatment and prevention of post-transplant lymphoproliferative disorders"</a>.)</p><p>Infection with <em>B. henselae</em> can also result in culture-negative endocarditis. Such patients have clinical manifestations similar to other patients with subacute bacterial endocarditis. A discussion of <em>Bartonella</em> endocarditis is presented separately. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a>.)</p><p class="headingAnchor" id="H3621862038"><span class="h1">APPROACH TO DIAGNOSIS</span><span class="headingEndMark"> — </span>Most patients with CSD present with typical clinical features, such as regional tender lymphadenopathy, with or without a preceding primary inoculation papular lesion. Atypical clinical findings include visceral organ involvement and ocular or neurologic manifestations. </p><p>A probable diagnosis is made based upon the characteristic clinical features and a history of recent cat or flea contact. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p>Serologic testing with an enzyme immunoassay (EIA) or indirect fluorescence assay (IFA) should be performed in an attempt to support the clinical impression [<a href="#rid24">24,71</a>]. (See <a class="local">'Serology'</a> below.)</p><p>However, serologic testing has serious shortcomings, and a negative serologic test does not rule out CSD in a patient with characteristic epidemiologic and clinical features. Thus, empiric therapy should be initiated in persons with a presumed diagnosis. (See  <a class="medical medical_review" href="/z/d/html/5530.html" rel="external">"Treatment of cat scratch disease"</a>.)</p><p>A lymph node or tissue biopsy is not routinely required for most patients who present with characteristic signs and symptoms of CSD, although it may be warranted in certain circumstances, such as a delayed resolution of systemic symptoms (eg, greater than five to seven days), or if an alternative diagnosis (eg, lymphoma or tuberculosis) is suspected. </p><p>If a biopsy sample is obtained, testing should include histology, <em>B</em>. <em>henselae</em> polymerase chain reaction (PCR) test, and Warthin-Starry staining. A positive <em>B</em>. <em>henselae</em> PCR test confirms the diagnosis, and a positive tissue Warthin-Starry stain provides strong support for the diagnosis of CSD (see <a class="local">'Diagnostic tests'</a> below). Testing to investigate for other disorders should also be performed. In an analysis of 786 lymph node specimens from patients with suspected CSD, infectious agents were identified in 391 of 786 (50 percent) of tissue samples [<a href="#rid72">72</a>]. Although the most commonly identified organism was <em>B. henselae</em> (245 patients, 31 percent), mycobacterial infection was diagnosed in 54 patients (7 percent). Malignancy was diagnosed in 47 of 181 patients in whom specimens suitable for histologic analysis were available (26 percent of those analyzed, 6 percent of total), and disease concurrent with CSD was diagnosed in 13 patients; no diagnosis was obtained in 350 patients (45 percent). The differential diagnosis of CSD is discussed below. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H3749137032"><span class="h1">DIAGNOSTIC TESTS</span></p><p class="headingAnchor" id="H2360544155"><span class="h2">Serology</span><span class="headingEndMark"> — </span>Several reference labs perform serologic testing for <em>Bartonella</em>. Two serologic methods, the indirect fluorescence assay (IFA) and enzyme immunosorbent assay (EIA), have been evaluated for diagnosis of CSD, but the commercially available assays use the IFA test. In general: </p><p class="bulletIndent1"><span class="glyph">●</span>IFA IgG titers &lt;1:64 suggest the patient does not have a current <em>Bartonella</em> infection; a low positive titer may represent past infection. </p><p></p><p class="bulletIndent1">Titers of 1:64 or 1:128 represent possible <em>Bartonella</em> infection, and repeat testing should be performed in 10 to 14 days. Titers ≥1:256 strongly suggest active or recent infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A positive IgM test strongly suggests acute disease (or very recent infection), but the production of IgM is usually brief. Thus, the serologic diagnosis of acute infection can be elusive.</p><p></p><p>However, a negative serologic test should not rule out CSD if there is a high clinical suspicion for disease. Although one study found that a higher proportion of patients with presumed CSD had an indirect IFA <em>B. henselae</em> IgG titer of ≥1:64 compared with healthy controls (88 versus 3 percent) [<a href="#rid4">4</a>], four subsequent studies from Europe reported problems with <em>B. henselae</em> IFA tests, including poor sensitivity [<a href="#rid73">73,74</a>] and specificity [<a href="#rid75">75,76</a>]. In a study of 156 children with suspected <em>B</em>.<em> henselae</em> infection, an alternative diagnosis was found among those with a <em>B. henselae</em> IgG titer of 1:128 or 1:256 in 34 and 24 percent, respectively [<a href="#rid77">77</a>].</p><p>The reported problems with the <em>B. henselae</em> IFA serology tests include:</p><p class="bulletIndent1"><span class="glyph">●</span>Significant cross-reactivity at the species level between <em>B. henselae</em> and <em>B. quintana</em>, especially for IgG assays.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sensitivity of the test does not appear to be optimal, especially with IgG assays.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prevalence of positive <em>Bartonella</em> serology in the general population is 4 to 6 percent, which creates false-positive test results.</p><p></p><p class="headingAnchor" id="H3877870376"><span class="h2">Culture</span><span class="headingEndMark"> — </span><em>B. henselae</em> is a fastidious, slow-growing, gram-negative bacterium that requires specific laboratory conditions for optimal growth. It is important to proactively communicate with the microbiology laboratory; by informing them that <em>Bartonella</em> is a potential diagnosis, the laboratory can optimize culture techniques and can extend the incubation period for a minimum of 21 days. As an example, blood culture samples should be collected in pediatric or adult isolator tubes (Wampole, Cranbury, NJ) or in blood tubes containing ethylenediaminetetraacetic acid (EDTA) to increase the probability of isolating <em>B. henselae</em>. </p><p>Plating samples onto either chocolate agar or heart infusion agar supplemented with 5 percent rabbit blood enhances isolation of organisms from subcultures. Optimally, the microbiology lab should use fresh agar plates and incubate them in 5 percent CO<sub>2</sub> at 35 to 37ºC for a minimum of 21 days. Even employing optimal techniques, most patients with CSD do not have <em>B. henselae</em> isolated from blood cultures.</p><p>Isolation of <em>B. henselae</em> from tissue samples remains very difficult, but successful isolation in patients with HIV has been reported by directly plating tissue homogenates onto agar and cocultivating with a bovine endothelial cell monolayer [<a href="#rid78">78</a>]. (See <a class="local">'Diagnostic tests'</a> above.)</p><p class="headingAnchor" id="H3249667798"><span class="h2">Histopathology</span><span class="headingEndMark"> — </span>Histopathologic examination of the primary inoculation lesion site reveals acellular areas of necrosis in the dermis. Histiocytes and epithelioid cells surround the areas of necrosis in multiple layers, with the innermost layer often showing a palisading arrangement. A zone of lymphocytes surrounds the histiocytes; multinucleated giant cells are variably present. Although these findings support a diagnosis of CSD, they should not be considered definitive.</p><p>The histopathologic findings in involved lymph nodes are nonspecific and depend upon the stage of the disease. Lymphoid hyperplasia is present initially, followed by the development of stellate granulomas. The lymph node centers are acellular and necrotic; histiocytes and peripheral lymphocytes surround these areas, similar to findings in skin samples. Microabscesses often develop and may become confluent at a later stage.</p><p>Warthin-Starry stain may demonstrate delicate pleomorphic <em>B. henselae</em> bacilli in chains, clumps, or filaments within areas of necrosis of involved lymph nodes and in the primary inoculation site of the skin. Although a positive Warthin-Starry stain does not provide a definitive diagnosis of CSD, it would strongly suggest a diagnosis of CSD if observed in conjunction with compatible clinical findings.</p><p class="headingAnchor" id="H3069058250"><span class="h2">Polymerase chain reaction</span><span class="headingEndMark"> — </span>Polymerase chain reaction (PCR) based tests for <em>Bartonella</em> on tissue or blood are available commercially. Intraocular fluid may be tested by PCR to confirm the diagnosis of <em>Bartonella</em> neuroretinitis. (See <a class="local">'Neuroretinitis'</a> above.)</p><p>The different PCR tests have utilized amplification of several distinct <em>Bartonella</em> gene regions [<a href="#rid24">24,79,80</a>]. Although these PCR tests have high specificity and can distinguish among the different <em>Bartonella</em> species, the sensitivity has not been optimal, with an estimated range of 40 to 76 percent. </p><p>When PCR is performed on tissue specimens, the timing of the biopsy may influence the results. As an example, one study found that PCR testing is more likely to be positive if it is performed during the first six weeks of infection [<a href="#rid21">21</a>]. In this study of 61 patients with CSD (defined as a compatible clinical presentation and serologic evidence of <em>B. henselae</em> infection), PCR was positive in only 10 of the 212 lymph node specimens on which this test was performed; 9 of the 10 patients with a positive result had a duration of illness of less than six weeks.</p><p>PCR testing of blood should not be used for routine evaluation of patients with suspected CSD. In one report, the sensitivity of PCR testing of serum samples in patients with CSD lymphadenitis was &lt;20 percent [<a href="#rid81">81</a>]. Although it is reasonable to perform PCR testing of blood in persons with atypical manifestations of CSD or in those with a serious systemic illness, the sensitivity is still low. As an example, in a study of patients with <em>Bartonella </em>endocarditis, PCR was positive in 25 of 70 (33 percent) serum samples, compared with 48 of 52 (92 percent) of PCR tests performed on valve tissue [<a href="#rid82">82</a>]. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a>.)</p><p class="headingAnchor" id="H1175540908"><span class="h2">Skin testing</span><span class="headingEndMark"> — </span>The CSD skin test, which was one of the tests incorporated into the original diagnostic criteria for CSD, is no longer used since other more specific and sensitive diagnostic tools are preferred [<a href="#rid1">1,2,6</a>]. In addition, the skin test antigen is not widely available, is not standardized, and is not approved by the US Food and Drug Administration (FDA) [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H4104578141"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H2069381586"><span class="h2">Fever and lymphadenopathy</span><span class="headingEndMark"> — </span>When evaluating a patient with lymphadenopathy and fever, it is important to consider alternative and/or concurrent diagnoses, including infectious and noninfectious disorders. Topic reviews that discuss the evaluation of patients with lymphadenopathy are found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">"Cervical lymphadenitis in children: Etiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/8386.html" rel="external">"Evaluation of peripheral lymphadenopathy in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2871.html" rel="external">"Peripheral lymphadenopathy in children: Etiology", section on 'Localized lymphadenopathy'</a>.)</p><p>The presence of tender lymph nodes suggests an infectious cause. The differential diagnosis depends, in part, on the individual's symptoms, where they have traveled or resided, and if they have had close contact with animals or someone who is ill [<a href="#rid34">34,83</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial adenitis</strong> – Bacterial adenitis is typically caused by <em>Staphylococcus aureus</em> or group A <em>Streptococcus</em>. CSD should be considered if a patient fails to respond to an initial antimicrobial regimen directed against these common bacterial pathogens, especially if the patient has epidemiologic risk factors for CSD (eg, exposure to kittens or cats). (See  <a class="medical medical_review" href="/z/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">"Methicillin-resistant <i>Staphylococcus aureus </i>infections in children: Epidemiology and clinical spectrum", section on 'SSTI'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mycobacterial infections</strong> – Mycobacterial infections (both <em>M. tuberculosis</em> and nontuberculous mycobacteria) can cause lymphadenopathy. Although it is difficult to differentiate tuberculosis from other causes of lymphadenitis on clinical grounds, tuberculosis should be suspected in patients from endemic regions. The diagnosis of mycobacterial lymphadenitis is established by histopathologic examination along with acid-fast bacilli smear and culture of lymph node material. (See  <a class="medical medical_review" href="/z/d/html/8001.html" rel="external">"Tuberculous lymphadenitis"</a> and  <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">"Nontuberculous mycobacterial lymphadenitis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral-associated lymphadenopathy</strong> – Viral-associated lymphadenopathy is often associated with infection due to Epstein-Barr virus, cytomegalovirus, or HIV. Such patients typically present with diffuse lymphadenopathy, whereas lymphadenopathy associated with CSD is usually limited to the node(s) near the site of inoculation. In addition, patients with viral-associated lymphadenopathy may have epidemiologic risk factors for a specific viral infection, such as a sick contact or a high-risk exposure. (See  <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">"Clinical manifestations and treatment of Epstein-Barr virus infection", section on 'Primary infection'</a> and  <a class="medical medical_review" href="/z/d/html/8289.html" rel="external">"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults", section on 'CMV mononucleosis'</a> and  <a class="medical medical_review" href="/z/d/html/86984.html" rel="external">"Acute and early HIV infection: Clinical manifestations and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toxoplasmosis </strong>– Both toxoplasmosis and CSD are associated with adenopathy and cat exposure. However, in contrast to toxoplasmosis, the lymph nodes in patients with CSD are usually tender, often have erythema of the overlying skin, and occasionally suppurate. Serologic testing or biopsy can help differentiate between these two conditions. (See <a class="local">'Lymphadenopathy'</a> above and  <a class="medical medical_review" href="/z/d/html/120887.html" rel="external">"Toxoplasmosis: Acute systemic disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other pathogens</strong> – Lymphadenopathy accompanied by a cutaneous inoculation lesion can be caused by <em>Nocardia</em> species, <em>Francisella tularensis</em>, <em>Erysipelothrix rhusiopathiae</em>, <em>Bacillus anthracis</em>, or <em>Yersinia pestis</em>. Other rare infectious causes of lymphadenopathy include histoplasmosis and sporotrichosis. Evaluation for a specific pathogen should be guided by the patient's exposure history (eg, fleas, ticks, water) and the location of the primary lesion. (See  <a class="medical medical_review" href="/z/d/html/3141.html" rel="external">"Tularemia: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Clinical syndromes'</a> and  <a class="medical medical_review" href="/z/d/html/5537.html" rel="external">"Erysipelothrix infection"</a> and  <a class="medical medical_review" href="/z/d/html/3131.html" rel="external">"Clinical manifestations, diagnosis, and treatment of plague (<i>Yersinia pestis</i> infection)"</a> and  <a class="medical medical_review" href="/z/d/html/3131.html" rel="external">"Clinical manifestations, diagnosis, and treatment of plague (<i>Yersinia pestis</i> infection)", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2455.html" rel="external">"Pathogenesis and clinical manifestations of disseminated histoplasmosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2457.html" rel="external">"Clinical features and diagnosis of sporotrichosis", section on 'Clinical presentation and differential diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/5515.html" rel="external">"Nocardia infections: Epidemiology, clinical manifestations, and diagnosis", section on 'Skin'</a>.)</p><p></p><p>Malignancies may be confused with CSD, including lymphoma, breast cancer, and sarcoma [<a href="#rid84">84</a>]. Other noninfectious causes include congenital and acquired cysts, Kawasaki disease, Kikuchi disease, and sarcoidosis. (See  <a class="medical medical_review" href="/z/d/html/4695.html" rel="external">"Clinical presentation and initial evaluation of non-Hodgkin lymphoma"</a> and  <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5507.html" rel="external">"Kikuchi disease"</a> and  <a class="medical medical_review" href="/z/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a>.)</p><p class="headingAnchor" id="H1083651569"><span class="h2">Neuroretinitis</span><span class="headingEndMark"> — </span>For patients with neuroretinitis, etiologies other than CSD that should be considered include sarcoid papillitis, syphilitic perineuritis, tuberculosis, Lyme disease, and rarely toxoplasmosis, toxocariasis, and leptospirosis. Pseudotumor cerebri can also mimic the much less frequent bilateral CSD. (See  <a class="medical medical_review" href="/z/d/html/7913.html" rel="external">"Clinical manifestations of Lyme disease in adults", section on 'Ocular manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Neurologic findings'</a> and  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5699.html" rel="external">"Toxoplasmosis: Ocular disease"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/83675.html" rel="external">"Patient education: Cat scratch disease (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/4005.html" rel="external">"Patient education: Animal and human bites (Beyond the Basics)"</a>) </p><p></p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – Cat scratch disease (CSD) is an infectious disease that is typically characterized by self-limited regional lymphadenopathy. <em>Bartonella henselae</em> is the etiologic agent in most cases of CSD. (See <a class="local">'Introduction'</a> above and <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – Multiple lines of evidence have directly linked CSD to exposure to cats, especially young cats and cats with fleas. CSD can result from a cat scratch or bite, as well as from a flea bite. It can also be spread via contact with cat saliva with a person's broken skin or mucosal surfaces (eg, mouth and eyes). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – In most children (85 to 90 percent), CSD manifests as a localized cutaneous and lymph node disorder, located near the site of organism inoculation. However, in some individuals, the organisms disseminate and infect the liver, spleen, eye, bone, or central nervous system. Patients with localized disease generally have a self-limited illness, whereas those with disseminated disease can have severe, or even life-threatening complications. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to diagnosis</strong> – For patients with CSD, a probable diagnosis is based upon a combination of clinical findings and a reported exposure to kittens, cats, or fleas. In such patients, the diagnosis is often supported by a positive serologic test for <em>B. henselae</em>. However, a negative serologic test should not rule out the diagnosis, and it is reasonable to initiate empiric therapy based upon a presumptive diagnosis. (See <a class="local">'Approach to diagnosis'</a> above and <a class="local">'Serology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of biopsy</strong> – A lymph node or tissue biopsy is not routinely required for most patients who present with characteristic signs and symptoms of CSD, although it may be warranted in certain circumstances, such as a delayed resolution of systemic symptoms (eg, greater than five to seven days), or if an alternative diagnosis (eg, lymphoma or tuberculosis) is suspected. If a biopsy sample is obtained, testing should include histology, Warthin-Starry staining, and a <em>B</em>. <em>henselae</em> polymerase chain reaction (PCR) test, as well as testing to investigate for other disorders. (See <a class="local">'Approach to diagnosis'</a> above and <a class="local">'Diagnostic tests'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J 1997; 16:163.</a></li><li><a class="nounderline abstract_t">Spach DH, Koehler JE. Bartonella-associated infections. Infect Dis Clin North Am 1998; 12:137.</a></li><li><a class="nounderline abstract_t">Wear DJ, Margileth AM, Hadfield TL, et al. Cat scratch disease: a bacterial infection. Science 1983; 221:1403.</a></li><li><a class="nounderline abstract_t">Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet 1992; 339:1443.</a></li><li><a class="nounderline abstract_t">Zangwill KM, Hamilton DH, Perkins BA, et al. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med 1993; 329:8.</a></li><li><a class="nounderline abstract_t">Szelc-Kelly CM, Goral S, Perez-Perez GI, et al. Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease. Pediatrics 1995; 96:1137.</a></li><li><a class="nounderline abstract_t">La Scola B, Liang Z, Zeaiter Z, et al. Genotypic characteristics of two serotypes of Bartonella henselae. J Clin Microbiol 2002; 40:2002.</a></li><li><a class="nounderline abstract_t">Kordick DL, Hilyard EJ, Hadfield TL, et al. Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease). J Clin Microbiol 1997; 35:1813.</a></li><li><a class="nounderline abstract_t">Giladi M, Avidor B, Kletter Y, et al. Cat scratch disease: the rare role of Afipia felis. J Clin Microbiol 1998; 36:2499.</a></li><li><a class="nounderline abstract_t">Tappero JW, Koehler JE, Berger TG, et al. Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med 1993; 118:363.</a></li><li><a class="nounderline abstract_t">Jacomo V, Kelly PJ, Raoult D. Natural history of Bartonella infections (an exception to Koch's postulate). Clin Diagn Lab Immunol 2002; 9:8.</a></li><li><a class="nounderline abstract_t">Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev Microbiol 2004; 58:365.</a></li><li><a class="nounderline abstract_t">Johnson A. Ocular complications of cat scratch disease. Br J Ophthalmol 2020; 104:1640.</a></li><li><a class="nounderline abstract_t">Jackson LA, Perkins BA, Wenger JD. Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health 1993; 83:1707.</a></li><li><a class="nounderline abstract_t">Ben-Ami R, Ephros M, Avidor B, et al. Cat-scratch disease in elderly patients. Clin Infect Dis 2005; 41:969.</a></li><li><a class="nounderline abstract_t">Apalsch AM, Nour B, Jaffe R. Systemic cat-scratch disease in a pediatric liver transplant recipient and review of the literature. Pediatr Infect Dis J 1993; 12:769.</a></li><li><a class="nounderline abstract_t">Bonatti H, Mendez J, Guerrero I, et al. Disseminated Bartonella infection following liver transplantation. Transpl Int 2006; 19:683.</a></li><li><a class="nounderline abstract_t">Thudi KR, Kreikemeier JT, Phillips NJ, et al. Cat scratch disease causing hepatic masses after liver transplant. Liver Int 2007; 27:145.</a></li><li><a class="nounderline abstract_t">Pischel L, Radcliffe C, Vilchez GA, et al. Bartonellosis in transplant recipients: A retrospective single center experience. World J Transplant 2021; 11:244.</a></li><li><a class="nounderline abstract_t">Windsor JJ. Cat-scratch disease: epidemiology, aetiology and treatment. Br J Biomed Sci 2001; 58:101.</a></li><li><a class="nounderline abstract_t">Ridder GJ, Boedeker CC, Technau-Ihling K, et al. Role of cat-scratch disease in lymphadenopathy in the head and neck. Clin Infect Dis 2002; 35:643.</a></li><li><a class="nounderline abstract_t">Nelson CA, Saha S, Mead PS. Cat-Scratch Disease in the United States, 2005-2013. Emerg Infect Dis 2016; 22:1741.</a></li><li><a class="nounderline abstract_t">Nawrocki CC, Max RJ, Marzec NS, Nelson CA. Atypical Manifestations of Cat-Scratch Disease, United States, 2005-2014. Emerg Infect Dis 2020; 26:1438.</a></li><li><a class="nounderline abstract_t">Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics 2008; 121:e1413.</a></li><li><a class="nounderline abstract_t">Tan TQ, Wagner ML, Kaplan SL. Bartonella (Rochalimaea) henselae hepatosplenic infection occurring simultaneously in two siblings. Clin Infect Dis 1996; 22:721.</a></li><li><a class="nounderline abstract_t">Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA 1994; 271:531.</a></li><li><a class="nounderline abstract_t">Chomel BB, Kasten RW, Floyd-Hawkins K, et al. Experimental transmission of Bartonella henselae by the cat flea. J Clin Microbiol 1996; 34:1952.</a></li><li><a class="nounderline abstract_t">Chomel BB, Abbott RC, Kasten RW, et al. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol 1995; 33:2445.</a></li><li><a class="nounderline abstract_t">Pennisi MG, Marsilio F, Hartmann K, et al. Bartonella species infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg 2013; 15:563.</a></li><li><a class="nounderline abstract_t">Foley JE, Chomel B, Kikuchi Y, et al. Seroprevalence of Bartonella henselae in cattery cats: association with cattery hygiene and flea infestation. Vet Q 1998; 20:1.</a></li><li><a class="nounderline abstract_t">Bouhsira E, Franc M, Lienard E, et al. The efficacy of a selamectin (Stronghold ®) spot on treatment in the prevention of Bartonella henselae transmission by Ctenocephalides felis in cats, using a new high-challenge model. Parasitol Res 2015; 114:1045.</a></li><li><a class="nounderline abstract_t">Bradbury CA, Lappin MR. Evaluation of topical application of 10% imidacloprid-1% moxidectin to prevent Bartonella henselae transmission from cat fleas. J Am Vet Med Assoc 2010; 236:869.</a></li><li><a class="nounderline abstract_t">Lappin MR, Davis WL, Hawley JR, et al. A flea and tick collar containing 10% imidacloprid and 4.5% flumethrin prevents flea transmission of Bartonella henselae in cats. Parasit Vectors 2013; 6:26.</a></li><li><a class="nounderline abstract_t">Moriarty RA, Margileth AM. Cat scratch disease. Infect Dis Clin North Am 1987; 1:575.</a></li><li><a class="nounderline abstract_t">Carithers HA. Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child 1985; 139:1124.</a></li><li><a class="nounderline abstract_t">Sander A, Frank B. Paronychia caused by Bartonella henselae. Lancet 1997; 350:1078.</a></li><li><a class="nounderline abstract_t">Charles RC, Sertic M, Neilan AM, Sohani AR. Case 11-2021: A 39-Year-Old Woman with Fever, Flank Pain, and Inguinal Lymphadenopathy. N Engl J Med 2021; 384:1448.</a></li><li><a class="nounderline abstract_t">Begres JM, Mangus CW. The flea's knees: A unique presentation of cat scratch disease. Am J Emerg Med 2021; 44:477.e5.</a></li><li><a class="nounderline abstract_t">Zangwill KM. Cat Scratch Disease and Bartonellaceae: The Known, the Unknown and the Curious. Pediatr Infect Dis J 2021; 40:S11.</a></li><li><a class="nounderline abstract_t">Lenoir AA, Storch GA, DeSchryver-Kecskemeti K, et al. Granulomatous hepatitis associated with cat scratch disease. Lancet 1988; 1:1132.</a></li><li><a class="nounderline abstract_t">Delahoussaye PM, Osborne BM. Cat-scratch disease presenting as abdominal visceral granulomas. J Infect Dis 1990; 161:71.</a></li><li><a class="nounderline abstract_t">Fretzayas A, Papadopoulos NG, Moustaki M, et al. Unsuspected extralymphocutaneous dissemination in febrile cat scratch disease. Scand J Infect Dis 2001; 33:599.</a></li><li><a class="nounderline abstract_t">Arisoy ES, Correa AG, Wagner ML, Kaplan SL. Hepatosplenic cat-scratch disease in children: selected clinical features and treatment. Clin Infect Dis 1999; 28:778.</a></li><li><a class="nounderline abstract_t">Margileth AM, Wear DJ, English CK. Systemic cat scratch disease: report of 23 patients with prolonged or recurrent severe bacterial infection. J Infect Dis 1987; 155:390.</a></li><li><a class="nounderline abstract_t">Hipp SJ, O'Shields A, Fordham LA, et al. Multifocal bone marrow involvement in cat-scratch disease. Pediatr Infect Dis J 2005; 24:472.</a></li><li><a class="nounderline abstract_t">Tsujino K, Tsukahara M, Tsuneoka H, et al. Clinical implication of prolonged fever in children with cat scratch disease. J Infect Chemother 2004; 10:227.</a></li><li><a class="nounderline abstract_t">Jacobs RF, Schutze GE. Bartonella henselae as a cause of prolonged fever and fever of unknown origin in children. Clin Infect Dis 1998; 26:80.</a></li><li><a class="nounderline abstract_t">Landes M, Maor Y, Mercer D, et al. Cat Scratch Disease Presenting as Fever of Unknown Origin Is a Unique Clinical Syndrome. Clin Infect Dis 2020; 71:2818.</a></li><li><a class="nounderline abstract_t">Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol 2000; 130:340.</a></li><li><a class="nounderline abstract_t">Ormerod LD, Dailey JP. Ocular manifestations of cat-scratch disease. Curr Opin Ophthalmol 1999; 10:209.</a></li><li><a class="nounderline abstract_t">Kalogeropoulos C, Koumpoulis I, Mentis A, et al. Bartonella and intraocular inflammation: a series of cases and review of literature. Clin Ophthalmol 2011; 5:817.</a></li><li><a class="nounderline abstract_t">Kalogeropoulos D, Asproudis I, Stefaniotou M, et al. Bartonella henselae- and quintana-associated uveitis: a case series and approach of a potentially severe disease with a broad spectrum of ocular manifestations. Int Ophthalmol 2019; 39:2505.</a></li><li><a class="nounderline abstract_t">Wear DJ, Malaty RH, Zimmerman LE, et al. Cat scratch disease bacilli in the conjunctiva of patients with Parinaud's oculoglandular syndrome. Ophthalmology 1985; 92:1282.</a></li><li><a class="nounderline abstract_t">Ridder GJ, Boedeker CC, Technau-Ihling K, Sander A. Cat-scratch disease: Otolaryngologic manifestations and management. Otolaryngol Head Neck Surg 2005; 132:353.</a></li><li><a class="nounderline abstract_t">Bhatti MT, Asif R, Bhatti LB. Macular star in neuroretinitis. Arch Neurol 2001; 58:1008.</a></li><li><a class="nounderline abstract_t">Suhler EB, Lauer AK, Rosenbaum JT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology 2000; 107:871.</a></li><li><a class="nounderline abstract_t">Reed JB, Scales DK, Wong MT, et al. Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology 1998; 105:459.</a></li><li><a class="nounderline abstract_t">Marra CM. Neurologic complications of Bartonella henselae infection. Curr Opin Neurol 1995; 8:164.</a></li><li><a class="nounderline abstract_t">Selby G, Walker GL. Cerebral arteritis in cat-scratch disease. Neurology 1979; 29:1413.</a></li><li><a class="nounderline abstract_t">Baylor P, Garoufi A, Karpathios T, et al. Transverse myelitis in 2 patients with Bartonella henselae infection (cat scratch disease). Clin Infect Dis 2007; 45:e42.</a></li><li><a class="nounderline abstract_t">Maman E, Bickels J, Ephros M, et al. Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis 2007; 45:1535.</a></li><li><a class="nounderline abstract_t">Giladi M, Maman E, Paran D, et al. Cat-scratch disease-associated arthropathy. Arthritis Rheum 2005; 52:3611.</a></li><li><a class="nounderline abstract_t">Hajjaji N, Hocqueloux L, Kerdraon R, Bret L. Bone infection in cat-scratch disease: a review of the literature. J Infect 2007; 54:417.</a></li><li><a class="nounderline abstract_t">Maggi RG, Mozayeni BR, Pultorak EL, et al. Bartonella spp. bacteremia and rheumatic symptoms in patients from Lyme disease-endemic region. Emerg Infect Dis 2012; 18:783.</a></li><li><a class="nounderline abstract_t">Erdem G, Watson JR, Hunt WG, et al. Clinical and Radiologic Manifestations of Bone Infection in Children with Cat Scratch Disease. J Pediatr 2018; 201:274.</a></li><li><a class="nounderline abstract_t">Ridder GJ, Technau-Ihling K, Sander A, Boedeker CC. Spectrum and management of deep neck space infections: an 8-year experience of 234 cases. Otolaryngol Head Neck Surg 2005; 133:709.</a></li><li><a class="nounderline abstract_t">Angelakis E, Pulcini C, Waton J, et al. Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after Tick Bite. Clin Infect Dis 2010; 50:549.</a></li><li><a class="nounderline abstract_t">Bandyopadhyay A, Burrage LC, Gonzalez BE. Pulmonary nodules in an immunocompetent child with cat scratch disease. Pediatr Infect Dis J 2013; 32:1390.</a></li><li><a class="nounderline abstract_t">Bosch X. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. JAMA 1998; 279:532.</a></li><li><a class="nounderline abstract_t">Bos F, Chauveau B, Ruel J, et al. Serious and Atypical Presentations of Bartonella henselae Infection in Kidney Transplant Recipients. Open Forum Infect Dis 2022; 9:ofac059.</a></li><li><a class="nounderline abstract_t">Margileth AM. Recent Advances in Diagnosis and Treatment of Cat Scratch Disease. Curr Infect Dis Rep 2000; 2:141.</a></li><li><a class="nounderline abstract_t">Rolain JM, Lepidi H, Zanaret M, et al. Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis 2006; 12:1338.</a></li><li><a class="nounderline abstract_t">Bergmans AM, Peeters MF, Schellekens JF, et al. Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 1997; 35:1931.</a></li><li><a class="nounderline abstract_t">Dupon M, Savin De Larclause AM, Brouqui P, et al. Evaluation of serological response to Bartonella henselae, Bartonella quintana and Afipia felis antigens in 64 patients with suspected cat-scratch disease. Scand J Infect Dis 1996; 28:361.</a></li><li><a class="nounderline abstract_t">Sander A, Posselt M, Oberle K, Bredt W. Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 1998; 5:486.</a></li><li><a class="nounderline abstract_t">Zbinden R, Michael N, Sekulovski M, et al. Evaluation of commercial slides for detection of immunoglobulin G against Bartonella henselae by indirect immunofluorescence. Eur J Clin Microbiol Infect Dis 1997; 16:648.</a></li><li><a class="nounderline abstract_t">Alattas NH, Patel SN, Richardson SE, et al. Pediatric Bartonella henselae Infection: The Role of Serologic Diagnosis and a Proposed Clinical Approach for Suspected Acute Disease in the Immunocompetent Child. Pediatr Infect Dis J 2020; 39:984.</a></li><li><a class="nounderline abstract_t">Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.</a></li><li><a class="nounderline abstract_t">Jensen WA, Fall MZ, Rooney J, et al. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol 2000; 38:1717.</a></li><li><a class="nounderline abstract_t">Allizond V, Costa C, Sidoti F, et al. Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study. PLoS One 2019; 14:e0211945.</a></li><li><a class="nounderline abstract_t">Vermeulen MJ, Diederen BM, Verbakel H, Peeters MF. Low sensitivity of Bartonella henselae PCR in serum samples of patients with cat-scratch disease lymphadenitis. J Med Microbiol 2008; 57:1049.</a></li><li><a class="nounderline abstract_t">Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 2015; 53:824.</a></li><li><a class="nounderline abstract_t">Klein JD. Cat scratch disease. Pediatr Rev 1994; 15:348.</a></li><li><a class="nounderline abstract_t">Dhal U, Hicklen RS, Tarrand J, Kontoyiannis DP. Cat Scratch Disease as a Mimicker of Malignancy. Open Forum Infect Dis 2021; 8:ofab500.</a></li></ol></div><div id="topicVersionRevision">Topic 5532 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9041596" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The expanding spectrum of Bartonella infections: II. Cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9494835" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Bartonella-associated infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6612349" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cat scratch disease: a bacterial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1351130" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8505963" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7491236" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12037055" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Genotypic characteristics of two serotypes of Bartonella henselae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9196200" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9705382" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cat scratch disease: the rare role of Afipia felis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8430982" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bacillary angiomatosis and bacillary splenitis in immunocompetent adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11777823" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Natural history of Bartonella infections (an exception to Koch's postulate).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15487942" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Molecular and cellular basis of bartonella pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32122915" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ocular complications of cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8259799" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cat scratch disease in the United States: an analysis of three national databases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16142661" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cat-scratch disease in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8018131" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Systemic cat-scratch disease in a pediatric liver transplant recipient and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16827686" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Disseminated Bartonella infection following liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17241393" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cat scratch disease causing hepatic masses after liver transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34164299" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Bartonellosis in transplant recipients: A retrospective single center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11440202" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cat-scratch disease: epidemiology, aetiology and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12203159" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Role of cat-scratch disease in lymphadenopathy in the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27648778" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cat-Scratch Disease in the United States, 2005-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32568056" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Atypical Manifestations of Cat-Scratch Disease, United States, 2005-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18443019" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Beyond cat scratch disease: widening spectrum of Bartonella henselae infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8729220" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bartonella (Rochalimaea) henselae hepatosplenic infection occurring simultaneously in two siblings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8301768" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8818889" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Experimental transmission of Bartonella henselae by the cat flea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7494043" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23813816" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bartonella species infection in cats: ABCD guidelines on prevention and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9477525" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Seroprevalence of Bartonella henselae in cattery cats: association with cattery hygiene and flea infestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25582566" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The efficacy of a selamectin (Stronghold®) spot on treatment in the prevention of Bartonella henselae transmission by Ctenocephalides felis in cats, using a new high-challenge model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20392182" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evaluation of topical application of 10% imidacloprid-1% moxidectin to prevent Bartonella henselae transmission from cat fleas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23351927" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A flea and tick collar containing 10% imidacloprid and 4.5% flumethrin prevents flea transmission of Bartonella henselae in cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3332886" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4061408" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cat-scratch disease. An overview based on a study of 1,200 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10213558" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Paronychia caused by Bartonella henselae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33852783" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Case 11-2021: A 39-Year-Old Woman with Fever, Flank Pain, and Inguinal Lymphadenopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33129648" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The flea's knees: A unique presentation of cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34042905" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cat Scratch Disease and Bartonellaceae: The Known, the Unknown and the Curious.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2896959" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Granulomatous hepatitis associated with cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1688602" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Cat-scratch disease presenting as abdominal visceral granulomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11525355" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Unsuspected extralymphocutaneous dissemination in febrile cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10825038" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hepatosplenic cat-scratch disease in children: selected clinical features and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3805768" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Systemic cat scratch disease: report of 23 patients with prolonged or recurrent severe bacterial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15876956" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Multifocal bone marrow involvement in cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15365864" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Clinical implication of prolonged fever in children with cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9455513" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Bartonella henselae as a cause of prolonged fever and fever of unknown origin in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31758684" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cat Scratch Disease Presenting as Fever of Unknown Origin Is a Unique Clinical Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11020414" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Ocular bartonellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10537781" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Ocular manifestations of cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21750616" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Bartonella and intraocular inflammation: a series of cases and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30852734" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Bartonella henselae- and quintana-associated uveitis: a case series and approach of a potentially severe disease with a broad spectrum of ocular manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4058889" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cat scratch disease bacilli in the conjunctiva of patients with Parinaud's oculoglandular syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15746844" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cat-scratch disease: Otolaryngologic manifestations and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11405817" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Macular star in neuroretinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10811077" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9499776" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7551113" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Neurologic complications of Bartonella henselae infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/573385" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cerebral arteritis in cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17638185" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Transverse myelitis in 2 patients with Bartonella henselae infection (cat scratch disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18190312" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Musculoskeletal manifestations of cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16255053" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Cat-scratch disease-associated arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17140668" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Bone infection in cat-scratch disease: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22516098" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Bartonella spp. bacteremia and rheumatic symptoms in patients from Lyme disease-endemic region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30041935" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinical and Radiologic Manifestations of Bone Infection in Children with Cat Scratch Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16274797" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Spectrum and management of deep neck space infections: an 8-year experience of 234 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20070235" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after Tick Bite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24030347" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pulmonary nodules in an immunocompetent child with cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9480364" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35211636" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Serious and Atypical Presentations of Bartonella henselae Infection in Kidney Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11095849" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Recent Advances in Diagnosis and Treatment of Cat Scratch Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17073081" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Lymph node biopsy specimens and diagnosis of cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9230358" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8893399" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Evaluation of serological response to Bartonella henselae, Bartonella quintana and Afipia felis antigens in 64 patients with suspected cat-scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9665953" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9352257" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Evaluation of commercial slides for detection of immunoglobulin G against Bartonella henselae by indirect immunofluorescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32826721" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Pediatric Bartonella henselae Infection: The Role of Serologic Diagnosis and a Proposed Clinical Approach for Suspected Acute Disease in the Immunocompetent Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1435899" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10790087" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Rapid identification and differentiation of Bartonella species using a single-step PCR assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30735549" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18628513" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Low sensitivity of Bartonella henselae PCR in serum samples of patients with cat-scratch disease lymphadenitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25540398" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Bartonella, a common cause of endocarditis: a report on 106 cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7971592" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Cat scratch disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34926712" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Cat Scratch Disease as a Mimicker of Malignancy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
